These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

31 related articles for article (PubMed ID: 9458475)

  • 1. [Cancer of the kidney in adults. Genetics].
    Prog Urol; 1997 Nov; 7(5):767-73. PubMed ID: 9458475
    [No Abstract]   [Full Text] [Related]  

  • 2. [Von Hippel-Lindau disease and renal cancer: 10 years of genetic progress. GEFVHL (French-Speaking Study Group on von Hippel-Lindau disease)].
    Richard S; Beroud C; Joly D; Chretien Y; Benoit G
    Prog Urol; 1998 Jun; 8(3):330-9. PubMed ID: 9689663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetics of renal cell carcinoma.
    Daniel LN; Linehan WM
    Semin Urol; 1989 Nov; 7(4):258-63. PubMed ID: 2575784
    [No Abstract]   [Full Text] [Related]  

  • 4. Genetic basis of renal cell cancer.
    Linehan WM; Gnarra JR; Lerman MI; Latif F; Zbar B
    Important Adv Oncol; 1993; ():47-70. PubMed ID: 8505056
    [No Abstract]   [Full Text] [Related]  

  • 5. Renal cancer genetics: von Hippel Lindau and other syndromes.
    Fleming S
    Int J Dev Biol; 1999; 43(5):469-71. PubMed ID: 10535326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inherited epithelial tumors of the kidney: old and new diseases.
    Zbar B
    Semin Cancer Biol; 2000 Aug; 10(4):313-8. PubMed ID: 10966853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The growing family of hereditary renal cell carcinoma.
    Richard S; Lidereau R; Giraud S
    Nephrol Dial Transplant; 2004 Dec; 19(12):2954-8. PubMed ID: 15507478
    [No Abstract]   [Full Text] [Related]  

  • 8. [Von Hippel-Lindau disease and molecular genetic diagnosis].
    Jensen AM; Bisgaard ML
    Ugeskr Laeger; 1999 Feb; 161(7):959-61. PubMed ID: 10051806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Von Hippel-Lindau disease with multiple malignant renal tumors: the importance of genetic testing.
    Shah DR; Hoeksema J; Korbet SM
    Clin Nephrol; 2000 Mar; 53(3):216-21. PubMed ID: 10749302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular cytogenetic characterization of early and late renal cell carcinomas in von Hippel-Lindau disease.
    Phillips JL; Ghadimi BM; Wangsa D; Padilla-Nash H; Worrell R; Hewitt S; Walther M; Linehan WM; Klausner RD; Ried T
    Genes Chromosomes Cancer; 2001 May; 31(1):1-9. PubMed ID: 11284029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solid renal tumor severity in von Hippel Lindau disease is related to germline deletion length and location.
    Maranchie JK; Afonso A; Albert PS; Kalyandrug S; Phillips JL; Zhou S; Peterson J; Ghadimi BM; Hurley K; Riss J; Vasselli JR; Ried T; Zbar B; Choyke P; Walther MM; Klausner RD; Linehan WM
    Hum Mutat; 2004 Jan; 23(1):40-6. PubMed ID: 14695531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifocal renal oncocytoma in a patient with Von Hippel-Lindau mutation.
    Fiske J; Patel R; Kau E; Pappas JG; Garcia RA; Taneja SS
    Urology; 2005 Dec; 66(6):1320. PubMed ID: 16360474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multifocal bilateral renal cell carcinoma and retinal angiomas in a patient with de novo von Hippel-Lindau disease: identification of a new germline mutation.
    Sessa A; Battini G; Meroni M; Pitingolo F; Righetti M; Ciotti P; Di Maria E; Bellone E; Ajmar F; Mandich P
    J Nephrol; 2005; 18(2):209-12. PubMed ID: 15931650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mapping of human chromosome 3 and its application to human diseases].
    Yamakawa K; Nakamura Y; Takahashi E
    Tanpakushitsu Kakusan Koso; 1993 Feb; 38(3):215-27. PubMed ID: 8098152
    [No Abstract]   [Full Text] [Related]  

  • 15. Cancer genetics: urological system. Part I.
    Lynch HT
    Nebr Med J; 1974 Nov; 59(11):422-7. PubMed ID: 4437672
    [No Abstract]   [Full Text] [Related]  

  • 16. Familial and hereditary renal cancer syndromes.
    Coleman JA
    Urol Clin North Am; 2008 Nov; 35(4):563-72; v. PubMed ID: 18992610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic organization and chromosomal localization of the human CUL2 gene and the role of von Hippel-Lindau tumor suppressor-binding protein (CUL2 and VBP1) mutation and loss in renal-cell carcinoma development.
    Clifford SC; Walsh S; Hewson K; Green EK; Brinke A; Green PM; Gianelli F; Eng C; Maher ER
    Genes Chromosomes Cancer; 1999 Sep; 26(1):20-8. PubMed ID: 10441001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetics in urogenital cancer.
    Lynch HT; Walzak MP
    Urol Clin North Am; 1980 Oct; 7(3):815-29. PubMed ID: 6256928
    [No Abstract]   [Full Text] [Related]  

  • 19. von Hippel-Lindau disease.
    Lancet; 1991 May; 337(8749):1065. PubMed ID: 1673497
    [No Abstract]   [Full Text] [Related]  

  • 20. cA479 (D3S719): a cosmid mapped telomeric of the Von Hippel Lindau disease gene contains the D3S18 locus.
    Liu W; Vance J; Smith DI
    Hum Mol Genet; 1992 Jun; 1(3):201. PubMed ID: 1303179
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.